ATE459622T1 - Tropanverbindungen - Google Patents
TropanverbindungenInfo
- Publication number
- ATE459622T1 ATE459622T1 AT08832769T AT08832769T ATE459622T1 AT E459622 T1 ATE459622 T1 AT E459622T1 AT 08832769 T AT08832769 T AT 08832769T AT 08832769 T AT08832769 T AT 08832769T AT E459622 T1 ATE459622 T1 AT E459622T1
- Authority
- AT
- Austria
- Prior art keywords
- tropane compounds
- tropane
- compounds
- formula
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68707P | 2007-10-25 | 2007-10-25 | |
PCT/US2008/012221 WO2009055077A1 (en) | 2007-10-25 | 2008-10-27 | Tropane compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE459622T1 true ATE459622T1 (de) | 2010-03-15 |
Family
ID=40287869
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT08832769T ATE459622T1 (de) | 2007-10-25 | 2008-10-27 | Tropanverbindungen |
Country Status (27)
Country | Link |
---|---|
US (1) | US8012956B2 (de) |
EP (1) | EP2074120B1 (de) |
JP (2) | JP5476307B2 (de) |
KR (1) | KR101578792B1 (de) |
CN (1) | CN101910168B (de) |
AT (1) | ATE459622T1 (de) |
AU (1) | AU2008317262B2 (de) |
BR (1) | BRPI0818893B8 (de) |
CA (1) | CA2703477C (de) |
CO (1) | CO6321232A2 (de) |
CY (1) | CY1110648T1 (de) |
DE (1) | DE602008000754D1 (de) |
DK (1) | DK2074120T3 (de) |
EA (1) | EA018999B1 (de) |
ES (1) | ES2342348T3 (de) |
HK (1) | HK1129390A1 (de) |
HR (1) | HRP20100292T1 (de) |
IL (1) | IL205202A0 (de) |
MX (1) | MX2010004493A (de) |
NZ (1) | NZ585137A (de) |
PL (1) | PL2074120T3 (de) |
PT (1) | PT2074120E (de) |
RS (1) | RS51346B (de) |
SG (1) | SG2012079653A (de) |
SI (1) | SI2074120T1 (de) |
WO (1) | WO2009055077A1 (de) |
ZA (1) | ZA201002987B (de) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2231666B1 (de) * | 2007-12-12 | 2015-07-29 | Rigel Pharmaceuticals, Inc. | Carbonsäureamid-, Sulfonamid- und Aminverbindungen gegen Stoffwechselerkrankungen |
FR2949467B1 (fr) | 2009-09-03 | 2011-11-25 | Sanofi Aventis | Nouveaux derives de 5,6,7,8-tetrahydroindolizine inhibiteurs d'hsp90, compositions les contenant et utilisation |
UY32940A (es) | 2009-10-27 | 2011-05-31 | Bayer Cropscience Ag | Amidas sustituidas con halogenoalquilo como insecticidas y acaricidas |
RU2012146986A (ru) | 2010-04-05 | 2014-05-20 | Сионоги Энд Ко., Лтд. | Цефемовые соединения, содержащие катехольную группу |
US20140080810A1 (en) | 2010-11-15 | 2014-03-20 | Exelixis, Inc. | Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture |
EP2740474A1 (de) | 2012-12-05 | 2014-06-11 | Instituto Europeo di Oncologia S.r.l. | Cyclopropylaminderivate als Hemmer von Histon-Demethylase-KDM1A |
WO2014107718A2 (en) * | 2013-01-07 | 2014-07-10 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Heat shock protein (hsp) inhibition and monitoring effectiveness thereof |
CN105636936B (zh) | 2013-08-21 | 2022-04-05 | 詹森生物制药有限公司 | 抗病毒化合物 |
CA2931088A1 (en) * | 2013-11-18 | 2015-05-21 | Del Mar Pharmaceuticals | Hplc analysis of impurities in dianhydrogalactitol |
CA2953005C (en) | 2014-05-30 | 2023-03-14 | Ieo - Istituto Europeo Di Oncologia S.R.L. | Cyclopropylamine compounds as histone demethylase inhibitors |
EP2949648A1 (de) | 2014-05-30 | 2015-12-02 | IEO - Istituto Europeo di Oncologia Srl | Cyclopropylaminderivate als Histondemethylaseinhibitoren |
US20170224670A1 (en) | 2014-10-14 | 2017-08-10 | Exelixis, Inc. | Drug Combination to Treat Melanoma |
JP2018521131A (ja) * | 2015-07-16 | 2018-08-02 | アクル ファーマ エービー | 標識である細胞毒性基または免疫調節基へ連結したslc6a3リガンドを用いる腎細胞癌の検出および治療 |
EP3588064B1 (de) * | 2017-02-23 | 2022-09-07 | IHI Corporation | Oh radikaldetektionssonde, oh-radikalmessvorrichtung und oh-radikalmessverfahren |
CN108164529B (zh) * | 2017-12-25 | 2020-04-24 | 三峡大学 | 一种小分子抑制剂sld9059及其在制药中的应用 |
CN112262137A (zh) | 2018-01-10 | 2021-01-22 | 阿林齐生物制药公司 | 四氢异喹啉化合物 |
CN111825702A (zh) * | 2019-04-22 | 2020-10-27 | 成都科岭源医药技术有限公司 | 一种氮杂*并吲唑类衍生物及其制备方法和用途 |
CN110698395B (zh) * | 2019-10-22 | 2021-05-25 | 杭州百诚医药科技股份有限公司 | 一种托吡司特的中间体的制备方法 |
CN112920078A (zh) * | 2019-12-05 | 2021-06-08 | 武汉珈汇精化科技有限公司 | 一种制备4-氰基苯甲酸甲酯的方法和一种制备4-氰基苯甲酸的方法 |
TW202136238A (zh) * | 2020-01-06 | 2021-10-01 | 大陸商廣東東陽光藥業有限公司 | RORγt抑制劑及其製備方法和用途 |
WO2022078414A1 (en) * | 2020-10-14 | 2022-04-21 | Ranok Therapeutics (Hangzhou) Co. Ltd. | Methods and compositions for targeted protein degradation |
CN114591192A (zh) * | 2020-12-04 | 2022-06-07 | 江西仰立新材料有限公司 | 一种n-环丙甲基苯胺类化合物的制备方法 |
EP4262797A1 (de) * | 2020-12-18 | 2023-10-25 | Merck Sharp & Dohme LLC | Amidosubstituierte pyridylverbindungen und verfahren zur verwendung davon zur behandlung von herpesviren |
CN112707809B (zh) * | 2020-12-30 | 2023-08-29 | 丽珠集团新北江制药股份有限公司 | 一种制备噁唑啉杀虫剂氟雷拉纳中间体的方法 |
CA3226271A1 (en) * | 2021-07-26 | 2023-02-02 | Zoetis Services Llc | Serotonin 5-ht2b inhibitory compounds |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0101641A3 (de) | 1982-07-22 | 1984-03-28 | Beecham Group Plc | Sulphonylamino-aza-bicycloalkyl-Derivate |
FR2738569B1 (fr) | 1995-09-12 | 1997-11-28 | Pf Medicament | Nouveaux derives naphtamide de 3 beta-amino azabicyclo octane ou nonane, leur procede de preparation, leur utilisation a titre de medicament antipsychotique |
DK0876366T3 (da) | 1996-01-15 | 2001-11-05 | Janssen Pharmaceutica Nv | Angiogenese-inhiberende pyridazinaminer |
HUP0202001A2 (hu) * | 2002-06-14 | 2005-08-29 | Sanofi-Aventis | DDP-IV gátló hatású azabiciklooktán- és nonánszármazékok |
ES2329133T3 (es) | 2003-05-28 | 2009-11-23 | Theravance, Inc. | Compuestos azabicicloalcanicos como antagonistas de receptores de muscarinicos. |
KR20060030482A (ko) * | 2003-06-24 | 2006-04-10 | 뉴로서치 에이/에스 | 신규한 8-아자-바이사이클로[3.2.1]옥탄 유도체 및모노아민 신경전달물질 재흡수 억제제로서의 이의 용도 |
GB0323236D0 (en) * | 2003-10-03 | 2003-11-05 | Pfizer Ltd | Chemical compounds |
US7309790B2 (en) | 2003-10-03 | 2007-12-18 | Pfizer Inc | Chemical compounds |
DK1731518T3 (da) * | 2004-03-31 | 2014-09-29 | Nippon Soda Co | Cyklisk aminsammensætning og skadedyrsbekæmpelsesmiddel |
FR2873693B1 (fr) * | 2004-07-29 | 2006-09-15 | Sanofi Synthelabo | Derives d'amino-tropane, leur preparation et leur application en therapeutique |
JP2008526923A (ja) | 2005-01-13 | 2008-07-24 | ノイロサーチ アクティーゼルスカブ | 新規8−置換8−アザ−ビシクロ[3.2.1]オクタン誘導体及びモノアミン神経伝達物質再取り込み阻害剤としてのそれらの使用 |
CN102127078A (zh) * | 2005-07-14 | 2011-07-20 | 安斯泰来制药株式会社 | Janus激酶3的杂环类抑制剂 |
BRPI0616839A2 (pt) * | 2005-10-06 | 2013-01-01 | Nippon Soda Co | agentes para controle de praga, e, compostos de amina cìclicos |
ES2382481T3 (es) * | 2006-09-01 | 2012-06-08 | Otsuka Agritechno Co., Ltd | Compuesto de N-piridilpiperidina, método para producir el mismo, y agente de control de plagas |
-
2008
- 2008-10-27 JP JP2010531069A patent/JP5476307B2/ja active Active
- 2008-10-27 AT AT08832769T patent/ATE459622T1/de active
- 2008-10-27 CA CA2703477A patent/CA2703477C/en active Active
- 2008-10-27 PT PT08832769T patent/PT2074120E/pt unknown
- 2008-10-27 CN CN200880122860.5A patent/CN101910168B/zh active Active
- 2008-10-27 RS RSP-2010/0220A patent/RS51346B/en unknown
- 2008-10-27 EA EA201070519A patent/EA018999B1/ru not_active IP Right Cessation
- 2008-10-27 DK DK08832769.7T patent/DK2074120T3/da active
- 2008-10-27 SI SI200830024T patent/SI2074120T1/sl unknown
- 2008-10-27 MX MX2010004493A patent/MX2010004493A/es active IP Right Grant
- 2008-10-27 KR KR1020107011444A patent/KR101578792B1/ko not_active Application Discontinuation
- 2008-10-27 BR BRPI0818893A patent/BRPI0818893B8/pt active IP Right Grant
- 2008-10-27 WO PCT/US2008/012221 patent/WO2009055077A1/en active Application Filing
- 2008-10-27 DE DE602008000754T patent/DE602008000754D1/de active Active
- 2008-10-27 AU AU2008317262A patent/AU2008317262B2/en active Active
- 2008-10-27 US US12/290,159 patent/US8012956B2/en active Active
- 2008-10-27 SG SG2012079653A patent/SG2012079653A/en unknown
- 2008-10-27 EP EP08832769A patent/EP2074120B1/de active Active
- 2008-10-27 NZ NZ585137A patent/NZ585137A/en unknown
- 2008-10-27 PL PL08832769T patent/PL2074120T3/pl unknown
- 2008-10-27 ES ES08832769T patent/ES2342348T3/es active Active
-
2009
- 2009-10-09 HK HK09109388.2A patent/HK1129390A1/xx unknown
-
2010
- 2010-04-19 IL IL205202A patent/IL205202A0/en active IP Right Grant
- 2010-04-29 ZA ZA2010/02987A patent/ZA201002987B/en unknown
- 2010-05-24 CO CO10061824A patent/CO6321232A2/es not_active Application Discontinuation
- 2010-05-24 HR HR20100292T patent/HRP20100292T1/hr unknown
- 2010-06-01 CY CY20101100483T patent/CY1110648T1/el unknown
-
2013
- 2013-12-13 JP JP2013257559A patent/JP5745021B2/ja active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE459622T1 (de) | Tropanverbindungen | |
EA201100037A1 (ru) | Органические соединения | |
CY1118199T1 (el) | Ενωσεις υποκατεστημενης πυραζολο[1,5] πυριμιδινης ως ενδιαμεσα στη συνθεση αναστολεων κινασης trk | |
EA201270254A1 (ru) | Производные 5-фторпиримидинона | |
EA201070786A1 (ru) | Бензофуропиримидиноны | |
UA107445C2 (uk) | 5-фторпіримідинові похідні як фунгіциди | |
SMAP201100019A (it) | Composti organici. | |
EA201201377A1 (ru) | Определенные аминопиридазины, композиции на их основе и способы их использования | |
BR112012018345A2 (pt) | "compostos de heteroarila, bem como composições e usos dos mesmos" | |
MA32383B1 (fr) | DÉRIVÉS D'INDAZOLES à SUBSTITUTIONS PHÉNYLE ET BENZODIOXYNYLE | |
WO2010003133A3 (en) | Cdk modulators | |
RS53301B (en) | TIOACETATE COMPOUNDS, COMPOSITIONS AND USE PROCEDURES | |
EA201270257A1 (ru) | Производные n1-сульфонил-5-фторпиримидинона | |
EA201170884A1 (ru) | Производные пиперидина, пригодные в качестве антагонистов орексина | |
UA108101C2 (xx) | Похідні n3-заміщених n1-сульфоніл-5-фторпіримідинонів | |
NO20085317L (no) | Imidazoazepinonforbindelser | |
UA106889C2 (uk) | Похідні n1-ацил-5-фторпіримідинону | |
ATE481395T1 (de) | Cyclohexylderivate | |
ATE533477T1 (de) | Pharmazeutische zusammensetzungen enthaltend irbesartan | |
RS53747B1 (en) | FENANTRENON UNITS, COMPOSITIONS AND METHODS | |
UY30235A1 (es) | Inhibidores de la adenilato ciclasa soluble | |
NZ590367A (en) | 9-Substituted-5-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials | |
EA200702590A1 (ru) | Ингибиторы растворимой аденилатциклазы | |
DOP2007000060A (es) | Inhibidores de la adenilato ciclasa soluble | |
DOP2007000059A (es) | Inhibidores de la adenilato ciclasa soluble |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 2074120 Country of ref document: EP |